Dorsey Wright & Associates’s Lydall, Inc. LDL Stock Holding History
Bought
Maintained
Sold
Other funds holding LDL
GCL
MF
AAM
VI
Dorsey Wright & Associates's LDL Position: Q3 2021 in Review
Dorsey Wright & Associates sold out of Lydall, Inc. (LDL) in Q3 2021, closing a stake of 940 shares — an estimated $57K sold.
Dorsey Wright & Associates first reported a position in LDL in Q4 2020 and held it in 3 quarters. The position peaked at $57K in Q2 2021. 158 funds tracked by Wall St. Rank hold LDL as of Q3 2021.
- Dorsey Wright & Associates reported no remaining Lydall, Inc. position as of Q3 2021 after selling out during the quarter.
- Dorsey Wright & Associates sold 940 Lydall, Inc. shares in Q3 2021, an estimated $57K.
- Dorsey Wright & Associates first reported a position in Lydall, Inc. in Q4 2020 and held it in 3 quarters.
- Dorsey Wright & Associates's Lydall, Inc. position peaked at $57K in Q2 2021.
- 158 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2021.
Based on Dorsey Wright & Associates's 13F filing for Q3 2021, filed 26 Oct 2021.